Apolipoprotein E isoforms and regulation of the innate immune response in brain of patients with Alzheimer's disease

Curr Opin Neurobiol. 2011 Dec;21(6):920-8. doi: 10.1016/j.conb.2011.08.002. Epub 2011 Sep 8.

Abstract

The largest genetic risk for late-onset Alzheimer's disease (AD) resides at the apolipoprotein E gene (APOE) locus, which has three common alleles (ɛ2, ɛ3, ɛ4) that encode three isoforms (apoE2, apoE3, apoE4). The very strong association of the APOE ɛ4 allele with AD risk and its role in the accumulation of amyloid β in brains of people and animal models solidify the biological relevance of apoE isoforms but do not provide mechanistic insight. The innate immune response is consistently observed in AD and is a likely contributor to neuronal injury and response to injury. Here we review emerging data showing that apoE isoform regulation of multiple facets of the innate immune response in the brain may alter AD not only through amyloid β-dependent mechanisms, but also through other, amyloid β-independent mechanisms.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alzheimer Disease / genetics*
  • Alzheimer Disease / immunology*
  • Alzheimer Disease / metabolism
  • Animals
  • Apolipoproteins E / genetics*
  • Apolipoproteins E / immunology*
  • Genetic Predisposition to Disease
  • Humans
  • Immunity, Innate / genetics*
  • Immunity, Innate / immunology*
  • Protein Isoforms / genetics
  • Protein Isoforms / immunology

Substances

  • Apolipoproteins E
  • Protein Isoforms